Using the Request for Quote (RFQ) form provided on this page, you can request competitive procurement options on part number DY812 with rapid responses always offered by our staff. To ensure that you locate and procure exactly what you need with ease, we list parts with as much information as we can. For example, part number DY812 It is listed as Nut Plain Hexagon. component manufactured by Allied Devices Corp, specifically under CAGE Code 29964. It is also accompanied by the NSN 5310009035966 for ease of organization, the first digits of the NSN indicating that the part belongs to FSC 5310 Nuts and Washers.
NSN Information for Part Number DY812 with NSN 5310-00-903-5966, 5310009035966
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
5310-00-903-5966 Item Description: Nut Plain Hexagon | 5310 | 009035966 | 0 | N | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | U | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Dy812 | 1 | 1 | C | A |
Characteristics Data of NSN 5310-00-903-5966, 5310009035966
MRC | Criteria | Characteristic |
---|---|---|
AAJD | THREAD CLASS | 2B |
AAJF | THREAD DIRECTION | RIGHT-HAND |
ADEA | NUT HEIGHT | 0.212 INCHES MINIMUM AND 0.226 INCHES MAXIMUM |
BZRR | THREAD SERIES | UNC |
CRTM | BEARING SURFACE TYPE | CHAMFERED OR WASHER FACED |
MATT | MATERIAL | STEEL COMP 303 OR STEEL COMP 304 OR STEEL COMP 440C OVERALL |
ACTA | NUT STYLE | HEXAGON |
AGAV | END ITEM IDENTIFICATION | MRAP- COUGAR AMBULANCE/RG-33 AUV; MRAP BUFFALO MK2A2 |
ASDB | WIDTH ACROSS FLATS | 0.4280 INCHES MINIMUM AND 0.4375 INCHES MAXIMUM |
CMLP | THREAD QUANTITY PER INCH | 20 |
CQJX | NOMINAL THREAD SIZE | 0.250 INCHES |
MDCL | MATERIAL DOCUMENT AND CLASSIFICATION | FED STD 66,AISI 303 OR SAE 30303 FED STD 1ST MATERIAL RESPONSE OR FED STD 66,AISI 304 OR SAE 30304 FED STD 2ND MATERIAL RESPONSE OR AISI 14140C FED STD 3RD MATERIAL RESPONSE OVERALL |
SFTT | SURFACE TREATMENT | PASSIVATE OVERALL |
STDC | SURFACE TREATMENT DOCUMENT AND CLASSIFICATION | QQ-P-35 FED SPEC SINGLE TREATMENT RESPONSE OVERALL |